VCYT
Veracyte
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: VCYT
- PEG Ratio
Based on the latest data from Jul 24, 2026, VCYT's PE to growth ratio sits at 0.32. This metric combines a PE of 51 with an earnings growth rate of 158.1%. Relative to the 0.31 average from the past four quarters, the PEG ratio is up by 4.1%.
VCYT PEG ratio history
Looking at the past two years, VCYT's PEG ratio has has been around 0.44 on average. At 0.32, today's PEG ratio sits 27% less than its historical average. Within the past two years, the Dec 2024 quarter saw the highest PEG reading at 0.94. At 0.18, the Mar 2026 quarter represented the lowest PEG ratio in this timeframe.
Veracyte PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.31 | 50.12 | 162.5% |
| 2024 | 0.94 | 123.75 | 131.4% |
| 2023 | N/A | N/A | -100% |
| 2022 | N/A | N/A | 54.1% |
| 2021 | N/A | N/A | -68.2% |
| 2020 | N/A | N/A | -144.4% |
| 2019 | N/A | N/A | 56.5% |
| 2018 | N/A | N/A | 31.9% |
| 2017 | N/A | N/A | 16.5% |
| 2016 | N/A | N/A | 16.2% |
| 2015 | N/A | N/A | 4.4% |
| 2014 | N/A | N/A | 77.9% |
| 2013 | N/A | N/A | 78.6% |
| 2012 | N/A | N/A | -15.2% |
| 2011 | N/A | N/A | N/A |
Veracyte PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.18 | 29.02 | 158.1% |
| Dec 2025 | 0.31 | 50.12 | 162.5% |
| Sep 2025 | 0.22 | 88.03 | 400% |
| Jun 2025 | 0.52 | 77.23 | 147.3% |
| Mar 2025 | 0.47 | 68.95 | 146.2% |
| Dec 2024 | 0.94 | 123.75 | 131.4% |
| Sep 2024 | N/A | N/A | 81.2% |
| Jun 2024 | N/A | N/A | -85% |
| Mar 2024 | N/A | N/A | -126.8% |
| Dec 2023 | N/A | N/A | -100% |
| Sep 2023 | N/A | N/A | -16.9% |
| Jun 2023 | N/A | N/A | 40.3% |
| Mar 2023 | N/A | N/A | 38.8% |
| Dec 2022 | N/A | N/A | 54.1% |
| Sep 2022 | N/A | N/A | 47.8% |
VCYT average PEG ratio chart
VCYT's PEG ratio today is lower than the 3, 5 and 10-year averages.
PEG comparison
Veracyte's PEG of 0.32 is higher than the industry average but lower than the Healthcare sector average. Looking at the Healthcare sector average of 0.53, Veracyte's PEG is 40% lower.
VCYT EPS growth
VCYT Price vs fair value
VCYT PEG vs peers
| Stock name | PEG ratio | Market cap |
|---|---|---|
| VCYT Veracyte Inc | 0.32 | $4.52B |
| MYGN Myriad Genetics Inc | N/A | $529.85M |
| CYTK Cytokinetics Inc | N/A | $10.05B |
Frequently asked questions
What is Veracyte's PEG ratio?
According to Jul 24, 2026 figures, VCYT's PEG ratio stands at 0.32.
What is the 3-year average PEG ratio for Veracyte (VCYT)?
Historical data over a 3-year period puts VCYT's average PEG ratio at 0.44.
What is the 5-year average PEG ratio for Veracyte (VCYT)?
Historical data over a 5-year period puts VCYT's average PEG ratio at 0.44.
What is the highest PEG ratio for VCYT?
VCYT's PEG ratio topped out at 0.94 during the Dec 2024 quarter - the highest in two years.
How does the current PEG ratio for VCYT compare to its historical average?
VCYT currently has a PEG ratio 27% below its 2-year average.
Why is Veracyte's PEG ratio so low?
At 0.32, VCYT's PEG ratio suggests the stock may be undervalued given its growth rate.
How is VCYT's PEG ratio calculated (Veracyte PEG ratio formula)?
To calculate the PEG ratio, take the company's PE ratio and divide by its earnings per share growth (YoY TTM). As of Jul 24, 2026, Veracyte has a PE ratio of 51. Earnings grew at 158.1% over the TTM period ending Mar 2026. Applying the formula, this gives a PEG ratio of 0.32. PEG RATIO(0.32) = PE RATIO(51) / EPS GROWTH(158.1%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.